Amy N. Sussman

1.2k total citations
20 papers, 346 citations indexed

About

Amy N. Sussman is a scholar working on Nephrology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amy N. Sussman has authored 20 papers receiving a total of 346 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amy N. Sussman's work include Renal Diseases and Glomerulopathies (4 papers), Diversity and Career in Medicine (3 papers) and Innovations in Medical Education (3 papers). Amy N. Sussman is often cited by papers focused on Renal Diseases and Glomerulopathies (4 papers), Diversity and Career in Medicine (3 papers) and Innovations in Medical Education (3 papers). Amy N. Sussman collaborates with scholars based in United States, United Kingdom and France. Amy N. Sussman's co-authors include Erika Bracamonte, Janet L. Neisewander, Bijin Thajudeen, Massimo Freschi, Josep Bou, Markus Graefen, Vittorio Bini, Giovanni Lughezzani, Vincenzo Scattoni and Bijan Ghaleh and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal Of Pathology and European Urology.

In The Last Decade

Amy N. Sussman

19 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amy N. Sussman United States 9 172 58 41 33 33 20 346
Gert Gabriëls Germany 14 101 0.6× 60 1.0× 104 2.5× 78 2.4× 38 1.2× 31 437
Longxing Cao China 8 201 1.2× 64 1.1× 63 1.5× 26 0.8× 8 0.2× 11 409
Nagwa Mohamed Egypt 11 64 0.4× 46 0.8× 56 1.4× 45 1.4× 5 0.2× 64 404
José Pablo Miramontes‐González Spain 15 73 0.4× 22 0.4× 136 3.3× 97 2.9× 10 0.3× 73 501
Hugo R. Ramos Argentina 5 53 0.3× 17 0.3× 86 2.1× 61 1.8× 25 0.8× 8 403
Anying Cheng China 7 59 0.3× 26 0.4× 149 3.6× 48 1.5× 15 0.5× 11 447
Yucheng Wang China 11 40 0.2× 75 1.3× 91 2.2× 42 1.3× 10 0.3× 35 324
Chie Kawahara Japan 10 41 0.2× 25 0.4× 77 1.9× 54 1.6× 11 0.3× 18 398
Matthieu Berry France 11 78 0.5× 36 0.6× 130 3.2× 80 2.4× 13 0.4× 24 481
Toru Okamura Japan 11 104 0.6× 22 0.4× 53 1.3× 138 4.2× 18 0.5× 46 347

Countries citing papers authored by Amy N. Sussman

Since Specialization
Citations

This map shows the geographic impact of Amy N. Sussman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy N. Sussman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy N. Sussman more than expected).

Fields of papers citing papers by Amy N. Sussman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy N. Sussman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy N. Sussman. The network helps show where Amy N. Sussman may publish in the future.

Co-authorship network of co-authors of Amy N. Sussman

This figure shows the co-authorship network connecting the top 25 collaborators of Amy N. Sussman. A scholar is included among the top collaborators of Amy N. Sussman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy N. Sussman. Amy N. Sussman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuan, Christina M., et al.. (2024). Protected Time for Program Administration among Nephrology Program Leadership in the United States. Clinical Journal of the American Society of Nephrology. 19(5). 583–590. 1 indexed citations
2.
Yuan, Christina M., et al.. (2023). Programmed to Fail: The Decline of Protected Time for Training Program Administration. Journal of Graduate Medical Education. 15(5). 532–535. 3 indexed citations
3.
Yuan, Christina M., et al.. (2022). Nephrology Program Director Protected Time for Program Administration in the United States. Clinical Journal of the American Society of Nephrology. 17(12). 1775–1782. 4 indexed citations
4.
Maynard, Sharon E., Amy N. Sussman, Oliver Lenz, et al.. (2021). Assessing Nephrology Fellows’ Skills in Communicating About Kidney Replacement Therapy and Kidney Biopsy: A Multicenter Clinical Simulation Study on Breaking Bad News. American Journal of Kidney Diseases. 78(4). 541–549. 7 indexed citations
5.
Thajudeen, Bijin, et al.. (2017). Proliferative Glomerulonephritis With Masked Monoclonal Deposits Responsive to Myeloma Therapy. Kidney International Reports. 2(6). 1233–1237. 5 indexed citations
6.
Moinuddin, Irfan, Machaiah Madhrira, Erika Bracamonte, Bijin Thajudeen, & Amy N. Sussman. (2016). Membranous nephropathy with crescents associated with levamisole-induced MPO-ANCA vasculitis. Pathology - Research and Practice. 212(7). 650–653. 14 indexed citations
7.
Moinuddin, Irfan, Bijin Thajudeen, Amy N. Sussman, et al.. (2016). Early Posttransplant Isolated v1 Lesion Does Not Need to Be Treated and Does Not Lead to Increased Fibrosis. SHILAP Revista de lepidopterología. 2016. 1–3. 1 indexed citations
8.
Bracamonte, Erika, et al.. (2015). Acute oxalate nephropathy due to pancreatic atrophy in newly diagnosed pancreatic carcinoma. Human Pathology. 48. 163–166. 3 indexed citations
9.
Thajudeen, Bijin, Asad Ali, Jarrod Mosier, et al.. (2015). Outcome of Patients on Combined Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy: A Retrospective Study. The International Journal of Artificial Organs. 38(3). 133–137. 25 indexed citations
10.
Moinuddin, Irfan, Erika Bracamonte, Bijin Thajudeen, et al.. (2015). Allergic Interstitial Nephritis Manifesting as a Striated Nephrogram. Case Reports in Medicine. 2015. 1–4. 4 indexed citations
11.
Matika, Ryan W., et al.. (2014). Hemodialysis Patients Have Plasmatic Hypercoagulability and Decreased Fibrinolytic Vulnerability. ASAIO Journal. 60(6). 716–721. 10 indexed citations
12.
Thajudeen, Bijin, et al.. (2014). Membranous Nephropathy With Crescents in a Patient With Hashimoto’s Thyroiditis. Medicine. 93(8). e63–e63. 8 indexed citations
13.
14.
Lazzeri, Massimo, Alexander Haese, Alexandre de la Taille, et al.. (2013). Serum Isoform [−2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2–10 ng/ml: A Multicentric European Study. European Urology. 63(6). 986–994. 166 indexed citations
15.
Thajudeen, Bijin, Amy N. Sussman, & Erika Bracamonte. (2013). A Case of Atypical Hemolytic Uremic Syndrome Successfully Treated with Eculizumab. Case Reports in Nephrology and Dialysis. 3(2). 139–146. 13 indexed citations
16.
Sussman, Amy N., et al.. (2013). Successful conversion to belatacept after thrombotic microangiopathy in kidney transplant patients. Clinical Transplantation. 27(4). 591–597. 19 indexed citations
17.
Sussman, Amy N. & Thomas Boyer. (2010). Management of Refractory Ascites and Hepatorenal Syndrome. Current Gastroenterology Reports. 13(1). 17–25. 8 indexed citations
18.
Sussman, Amy N., et al.. (2009). SPARC Accelerates Disease Progression in Experimental Crescentic Glomerulonephritis. American Journal Of Pathology. 174(5). 1827–1836. 8 indexed citations
19.
Sussman, Amy N., Ly T.L. Tran-Nguyen, & Janet L. Neisewander. (1997). Acute reserpine administration elicits long-term spontaneous oral dyskinesia. European Journal of Pharmacology. 337(2-3). 157–160. 25 indexed citations
20.
Neisewander, Janet L., et al.. (1996). Effects of amphetamine and 6-hydroxydopamine lesions on reserpine-induced oral dyskinesia. European Journal of Pharmacology. 305(1-3). 13–21. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gert Gabriëls Breakdown of academic impact, for papers by Longxing Cao Breakdown of academic impact, for papers by Nagwa Mohamed Breakdown of academic impact, for papers by José Pablo Miramontes‐González Breakdown of academic impact, for papers by Hugo R. Ramos Breakdown of academic impact, for papers by Anying Cheng Breakdown of academic impact, for papers by Yucheng Wang Breakdown of academic impact, for papers by Chie Kawahara Breakdown of academic impact, for papers by Matthieu Berry Breakdown of academic impact, for papers by Toru Okamura
Rankless by CCL
2026